113 related articles for article (PubMed ID: 593815)
21. Oral contraceptives, hormone therapy and cardiovascular risk.
Shapiro S
Climacteric; 2008 Oct; 11(5):355-63. PubMed ID: 18781479
[TBL] [Abstract][Full Text] [Related]
22. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
Contraception; 1998 May; 57(5):315-24. PubMed ID: 9673838
[TBL] [Abstract][Full Text] [Related]
23. [Spontaneous mesenteric venous thrombosis, a rare complication of oral contraceptives (author's transl)].
Hofbauer F; Depisch D; Skodler D
Wien Klin Wochenschr; 1980 Mar; 92(6):191-4. PubMed ID: 7395232
[TBL] [Abstract][Full Text] [Related]
24. The Royal College of General Practitioners' Oral Contraception Study: some recent observations.
Kay CR
Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858
[TBL] [Abstract][Full Text] [Related]
25. [Acute coronary thrombosis in a 28 year-old woman].
Motté G; Vogel M; Coatantiec G; Mariette P; Welti J-J
Arch Mal Coeur Vaiss; 1975 Jan; 68(1):91-6. PubMed ID: 804881
[TBL] [Abstract][Full Text] [Related]
26. [Estrogen-progestogen agents and megaloblastic anemia].
Mottier D; Jouquan J; Baccino E; Cleuziou A; Pennec Y; Kerlan V; Garo B; Bergeret G
J Gynecol Obstet Biol Reprod (Paris); 1984; 13(6):707-10. PubMed ID: 6520357
[TBL] [Abstract][Full Text] [Related]
27. Oral contraceptives and myocardial infarction.
Bader M
N Engl J Med; 1977 Aug; 297(8):449. PubMed ID: 882119
[TBL] [Abstract][Full Text] [Related]
28. [Significance of hormonal contraceptives for coronary heart disease].
Gohlke-Bärwolf C
Herz; 1987 Aug; 12(4):263-75. PubMed ID: 3308662
[TBL] [Abstract][Full Text] [Related]
29. [Oral contraceptives and risk of myocardial infarction].
Sørensen MB; Ottesen BS
Ugeskr Laeger; 2002 Apr; 164(18):2415-6. PubMed ID: 12024850
[No Abstract] [Full Text] [Related]
30. [Oestrogen containing oral contraceptives decrease prostacyclin production (author's transl)].
Ylikorkala O; Puolakka J; Vinnikka L
Contracept Fertil Sex (Paris); 1981 Sep; 9(9):547-9. PubMed ID: 12337641
[TBL] [Abstract][Full Text] [Related]
31. [The thrombotic risk from oestrogen-progestogen contraceptives : pathogenetic elements (author's transl)].
Warniez C; Loffredo V
Rev Fr Gynecol Obstet; 1977 Feb; 72(2):141-5. PubMed ID: 877472
[No Abstract] [Full Text] [Related]
32. [Myocardial infarction following administration of oral contraceptive agents. 3 cases].
Benacerraf A; Veron P; Morin B; Castillo-Fenoy A; Chapuis A; Ziskind B
Nouv Presse Med; 1977 Jan; 6(1):22-6. PubMed ID: 834545
[TBL] [Abstract][Full Text] [Related]
33. The difficulty in diagnosing idiopathic arterial calcification of infancy, its variation in presentation, and the importance of autopsy.
Hault K; Sebire NJ; Ho SY; Sheppard MN
Cardiol Young; 2008 Dec; 18(6):624-7. PubMed ID: 18842162
[TBL] [Abstract][Full Text] [Related]
34. [Oral contraceptives: pharmacotherapy of normal women (author's transl)].
Bühler FR
Schweiz Rundsch Med Prax; 1976 Jan; 65(1):3-5. PubMed ID: 1250821
[TBL] [Abstract][Full Text] [Related]
35. Oral contraception, ovarian disorders and tobacco in myocardial infarction of woman.
Leone A; Lopez M
Pathologica; 1986; 78(1054):237-42. PubMed ID: 3822565
[TBL] [Abstract][Full Text] [Related]
36. Changes in causes of sudden deaths by decade in patients with coronary arterial lesions due to Kawasaki disease.
Tsuda E; Arakaki Y; Shimizu T; Sakaguchi H; Yoshimura S; Yazaki S; Echigo S
Cardiol Young; 2005 Oct; 15(5):481-8. PubMed ID: 16164786
[TBL] [Abstract][Full Text] [Related]
37. [Myocardial infarction in young women: apropos of 22 cases. Pathogenic and prognostic approach].
Pasquali V; Le Helloco A; Leborgne O; Bedossa M; Laurent M; Almange C; Leborgne P
Arch Mal Coeur Vaiss; 1992 Jan; 85(1):53-7. PubMed ID: 1550434
[TBL] [Abstract][Full Text] [Related]
38. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
[TBL] [Abstract][Full Text] [Related]
39. [Contraception in preclimacteric women with special regard to oral contraceptives (author's transl)].
Salzer H; Schneider WH; Eppel W
Wien Med Wochenschr; 1980 Mar; 130(6):218-21. PubMed ID: 7395249
[TBL] [Abstract][Full Text] [Related]
40. [Cerebral pseudotumor and oral contraceptives (cerebral case)].
Jandolo B; Casaglia P; Morace E
Riv Neurobiol; 1978; 24(1-2):106-8. PubMed ID: 757641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
